Akkure Genomics

12/05/2023

It's "Clinical Trials Day" on May 20th and Akkure is offering all charities the ability to add our new AI-powered clinical trials finder to use on their websites for free. Our finder searches over 80,000 trials around the world that are actively recruiting.
If you would like to find out more information just click on the link below.

Free Global Clinical Trials Finder Now available for charities in advance of World Clinical Trials Day on 20th May 2023 We are delighted to announce the launch of our Global Clinical Trials Finder for charities. The finder is free to use for all charities worldwide and their commuties and leverages....

27/04/2023

NEWS: We're excited to announce that today, in advance of World Clinical Trials day on 20th May, we're launching a free "Global Clinical Trial Finder" for charities to use worldwide.
This follows on from our recent deployment of the world’s first “Global Genomic Clinical Trial Finder” leveraging an exclusive innovation partnership with the Microsoft AI. The free version of our “finder” can be easily added to a charity's website and is free to use for both charities and their communities. Please share with any charities you may know that would be interested. You can find out more at the link below.

Akkure recently deployed the world's first “Global Genomic Clinical Trial Finder” leveraging a world exclusive early adopter innovation partnership with the Microsoft AI for Health team.

19/04/2023

"Akkure Genomics Deploys Clinical Trials Solution via Partnership with Microsoft AI for Precision Medicine"

At Akkure Genomics, our team of AI experts, doctors and geneticists have worked with Microsoft Health to create an AI-powered translational health solution for hospitals and clinical research centres. Our “Clinical Trial Matcher” is an enterprise grade AI model that matches patients to potentially suitable clinical trials, according to the trial’s eligibility criteria and patient data.

Today there are more than 82,000 clinical trials actively recruiting participants worldwide, however up to 48 percent fail to meet clinical trial enrolment targets. We're leveraging Microsoft's "Health Insights", which empowers our own AI and digital DNA platform capabilities, to help patients get matched to clinical trials based on their individual medical diagnoses, thus boosting enrollment, improving the chances of finding a precision-matched trial and accelerating discovery of new therapeutics and cures.

Find our more at from Microsoft Health's Partner Group Manager here:

Today, I’m excited to announce Project Health Insights Preview. Project Health Insights is a service that derives insights based on patient data and includes pre-built models that aim to power key high value scenarios in the health domain. The models receive patient data in different modalitie...

31/01/2023

Akkure Genomics is delighted to showcase our range of digital solutions for precision medicine, including our clinical trials platform, with Enterprise Ireland MENA's trade mission to Arab Health in Dubai this week. Pictured below, our CEO Dr Oran Rigby meeting with Dara Calleary the Irish Minister for Trade Promotion and Digital on the stand at day 2 of the conference

22/12/2022

A recent medical breakthrough saw 13 year old Alyssa cleared of cancer that was previously thought to be incurable.

The technique is called "Base editing", involving editing the building blocks of our genetic code to help fight cancer.

Swipe to learn more about Base Editing and the technique's implications for future cancer therapies 👉🏽

15/12/2022

Our Chief Medical Officer Prof. Amy Hollingsworth dropped into Ireland's Christmas FM this week to lend Akkure's support to the radio station and celebrate our sponsorship of the "Healthy Christmas" feature on the station this year. Amy is pictured below with Christmas FM co-founder Daragh O'Sullivan. This year Christmas FM is supporting four of Ireland's biggest children charities and you can donate @ www.Christmasfm.com

05/12/2022

We’re delighted to announce our sponsorship of a "Healthy Christmas" on Christmas FM this year. We’re proud to be partnering with an incredible organisation supporting important charities across the country. Keep an ear out for us if you're listening!

30/11/2022

Our "preventative health insights" via our Digital DNA Twins, let you learn more about your future self. Find out more at Akkure.com

28/11/2022

You’ve probably seen the news coverage of Chris Hemsworth’s genetic discovery- that he has an increased chance of developing Alzheimer’s disease due to carrying two copies of the APOE4 gene.

So what does this information actually mean?

The most important thing to note in regards to this story is that predisposition is NOT a diagnosis.

The APOE4 gene is considered to be the most important genetic risk factor for Alzheimer’s disease.

Approximately 25% of people carry one copy of APOE4, and 2-3% of people carry two copies.

Chris Hemsworth falls into the latter category, meaning he inherited the gene from both his mother and his father.

Knowing that you have an increased chance of developing Alzheimer’s, like Chris Hemsworth, enables you to make informed decisions about your health and lifestyle, and employ available preventative measures to reduce disease risk.

This is called preventative medicine, and it’s what we’re all about at Akkure Genomics 🧬

Read more about our genomic products and preventative medicine at akkure.com

22/11/2022

Akkure provides preventative health insights via your DNA which will show you the likelihood of you developing some of Ireland's most common medical conditions based on certain genes. Our reports start from just €200. See our video for more detail.

21/11/2022

Our Medical Digital Twins are now available in Ireland and include a DNA report that highlights your potential risk of developing some of Ireland's most common medical conditions. Black Friday Offer of 20% off using code BFRI20 at Akkure.com. All your data is 100% owned and controlled by you at Akkure Ireland and our medical grade labs are ISO certified.

21/11/2022

Our current round of fundraising received some nice coverage in the Sunday Business Post this weekend. The fundraising round is still live on Spark CrowdFunding if you're interested in getting involved. See more below: "Medtech firm which developed artificial intelligence software to match patients with clinical trials raises amount between grants and crowdfunding":

Medtech firm which developed artificial intelligence software to match patients with clinical trials raises amount between grants and crowdfunding